Legend Biotech
autologous car for cell lymphoma | Legend Biotech
Company
Deck Type
IPO
Sector
Industry
Deck date
May 2020
Slide
23 of 42
Related slides by other companies
AstraZeneca
Results
November 2024
autologous anti and anti car lupus anti pain pais a | AstraZeneca
CARGO Therapeutics
IPO
March 2024
an autologous car cell product candidate designed to target | CARGO Therapeutics
Kymera
Investor Day
December 2021
first in class opportunity to address driven pathology across diverse indications us us us us of go | Kymera
AstraZeneca
Results
November 2024
autologous anti and anti car blood cancers anti | AstraZeneca
Other recent decks by Legend Biotech
See all presentations (6 decks)
Investor Presentation
April 2025
Results
November 2024
Investor Presentation
January 2024
Results
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights